<DOC>
	<DOCNO>NCT01296022</DOCNO>
	<brief_summary>This randomize controlled trial outline advantage disadvantage subcutaneous implantable cardioverter defibrillator ( ICD ) compare transvenous ICD .</brief_summary>
	<brief_title>A PRospective , rAndomizEd Comparison subcuTaneOous tRansvenous ImplANtable Cardioverter Defibrillator Therapy</brief_title>
	<detailed_description>Background study : The use implantable cardioverter defibrillator ( ICDs ) establish therapy prevention death ventricular arrhythmia . Recently new subcutaneous ICD introduce , eliminate need transvenous lead placement heart mandatory transvenous ICD . The new subcutaneous ICD therapy already prove feasible safe approve therapy Europe . It likely eliminate need transvenous lead placement substantially reduce implantation related complication elongate lead longevity thus reduce inappropriate shock associate lead fracture . On hand unclear whether lack capability provide antitachy-pacing ( ATP ) subcutaneous ICD may limitation patient frequent recurrent ventricular tachycardia . This randomize controlled trial outline advantage disadvantage subcutaneous ICD . Objectives study : ( 1 ) To compare subcutaneous ICD transvenous ICD major adverse event ( i.e . inappropriate shock , acute chronic implant related complication lead- device relate complication ) . ( 2 ) To determine degree lack ATP function lead appropriate shock patient subcutaneous ICD . Study design : Multicenter , prospective , randomize control trial either treatment transvenous ICD subcutaneous ICD ( 1:1 ) . Study population : 2x425 patient class I IIa indication ICD therapy without indication pacing .</detailed_description>
	<criteria>Patients 18 year old Patients class I IIa indication ICD therapy accord ACC/AHA/ESC 2006 Guidelines Management Patients With Ventricular Arrhythmias Prevention Sudden Cardiac Death Patients document therapy refractory monomorphic ventricular tachycardia Patients indication pace therapy Patients ventricular tachycardia le 170 bpm Patients fail appropriate QRS/Twave sense SICD ECG patient screen tool provide Cameron Health/Boston Scientific Patients incessant ventricular tachycardia Patients serious know concomitant disease life expectancy le one year Patients circumstance prevent followup ( permanent home address , transient , etc . ) Patients previous ICD implant Patient receive cardiac contractility modulation therapy likely receive cardiac contractility modulation therapy . Patients unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Heart rhythm disturbance</keyword>
	<keyword>Implantable cardiac defibrillator</keyword>
</DOC>